Ideaya Biosciences Inc. (IDYA) NASDAQ
$38.64 (1.21) (-3.04%)
Market Cap: $2.98B
As of 04/25/24 10:25 AM EDT. Market open.
Ideaya Biosciences Inc. (IDYA)
NASDAQ
$38.64
(1.21) (-3.04%)
Market Cap: $2.98B
As of 04/25/24 10:25 AM EDT. Market open.
ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. founded in 2015, ideaya’s investors include 5am ventures (5am), canaan partners (canaan), celgene, wuxi healthcare ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Ruiz Briseno Andres | See Remarks | Feb 09, 2024 | Sale | $46.02 | 2,000 | 92,045 | 24,531 | Feb 13, 2024, 04:59 PM |
Hata Yujiro S | President and CEO | Feb 09, 2024 | Option Exercise | $4.31 | 23,557 | 101,531 | 701,444 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 08, 2024 | Option Exercise | $4.31 | 75,815 | 326,763 | 753,702 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 09, 2024 | Sale | $45.54 | 23,557 | 1,072,715 | 677,887 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 08, 2024 | Sale | $45.15 | 75,815 | 3,422,835 | 677,887 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 01, 2024 | Option Exercise | $4.31 | 628 | 2,707 | 678,515 | Feb 05, 2024, 06:05 PM |
Hata Yujiro S | President and CEO | Feb 01, 2024 | Sale | $45.00 | 628 | 28,260 | 677,891 | Feb 05, 2024, 06:05 PM |
Ruiz Briseno Andres | See Remarks | Jan 22, 2024 | Sale | $42.03 | 2,000 | 84,050 | 26,531 | Jan 24, 2024, 07:12 PM |
Ruiz Briseno Andres | See Remarks | Jan 12, 2024 | Sale | $38.01 | 2,000 | 76,026 | 28,531 | Jan 17, 2024, 05:41 PM |
Hata Yujiro S | President and CEO | Jan 16, 2024 | Option Exercise | $4.31 | 62,739 | 270,405 | 740,626 | Jan 17, 2024, 05:40 PM |
Hata Yujiro S | President and CEO | Jan 12, 2024 | Option Exercise | $4.31 | 12,261 | 52,845 | 690,148 | Jan 17, 2024, 05:40 PM |
Hata Yujiro S | President and CEO | Jan 16, 2024 | Sale | $40.17 | 62,739 | 2,519,968 | 677,887 | Jan 17, 2024, 05:40 PM |
Hata Yujiro S | President and CEO | Jan 12, 2024 | Sale | $40.04 | 12,261 | 490,913 | 677,887 | Jan 17, 2024, 05:40 PM |
Throne Jason | Chief Legal Officer | Dec 18, 2023 | Option Exercise | $7.01 | 10,000 | 70,100 | 10,000 | Dec 19, 2023, 05:37 PM |
Throne Jason | Chief Legal Officer | Dec 15, 2023 | Option Exercise | $13.34 | 10,000 | 133,400 | 10,000 | Dec 19, 2023, 05:37 PM |
Throne Jason | Chief Legal Officer | Dec 15, 2023 | Sale | $35.04 | 10,000 | 350,371 | 0 | Dec 19, 2023, 05:37 PM |
Hata Yujiro S | President and CEO | Dec 15, 2023 | Option Exercise | $4.31 | 75,000 | 323,250 | 752,887 | Dec 19, 2023, 05:34 PM |
Hata Yujiro S | President and CEO | Dec 15, 2023 | Sale | $35.03 | 75,000 | 2,627,618 | 677,887 | Dec 19, 2023, 05:34 PM |
Ruiz Briseno Andres | See Remarks | Dec 14, 2023 | Sale | $34.00 | 2,000 | 68,002 | 30,859 | Dec 18, 2023, 05:45 PM |
Throne Jason | Chief Legal Officer | Nov 03, 2023 | Option Exercise | $12.86 | 5,163 | 66,396 | 5,163 | Nov 07, 2023, 05:47 PM |
Throne Jason | Chief Legal Officer | Nov 03, 2023 | Sale | $30.09 | 5,163 | 155,360 | 0 | Nov 07, 2023, 05:47 PM |
Throne Jason | Chief Legal Officer | Sep 12, 2023 | Option Exercise | $12.86 | 1,000 | 12,860 | 1,000 | Sep 14, 2023, 05:23 PM |
Throne Jason | Chief Legal Officer | Sep 12, 2023 | Sale | $30.01 | 1,000 | 30,005 | 500 | Sep 14, 2023, 05:23 PM |
Throne Jason | Chief Legal Officer | Sep 01, 2023 | Option Exercise | $12.86 | 2,100 | 27,006 | 2,100 | Sep 06, 2023, 06:37 PM |
Throne Jason | Chief Legal Officer | Sep 05, 2023 | Option Exercise | $12.86 | 1,737 | 22,338 | 1,737 | Sep 06, 2023, 06:37 PM |
Throne Jason | Chief Legal Officer | Sep 05, 2023 | Sale | $30.03 | 1,737 | 52,160 | 0 | Sep 06, 2023, 06:37 PM |
Throne Jason | Chief Legal Officer | Sep 01, 2023 | Sale | $30.03 | 2,100 | 63,063 | 0 | Sep 06, 2023, 06:37 PM |
Ruiz Briseno Andres | See Remarks | Sep 01, 2023 | Sale | $30.01 | 2,000 | 60,016 | 32,531 | Sep 06, 2023, 06:36 PM |
Stone Paul A. | Chief Financial Officer | Aug 29, 2023 | Sale | $28.87 | 5,000 | 144,352 | 9,303 | Aug 31, 2023, 05:49 PM |
Stone Paul A. | Chief Financial Officer | Aug 21, 2023 | Sale | $26.40 | 978 | 25,819 | 14,303 | Aug 23, 2023, 06:31 PM |
Stone Paul A. | Chief Financial Officer | Aug 18, 2023 | Sale | $26.38 | 3,822 | 100,820 | 15,281 | Aug 18, 2023, 06:33 PM |
Stone Paul A. | Chief Financial Officer | Aug 16, 2023 | Sale | $26.43 | 200 | 5,285 | 19,203 | Aug 18, 2023, 06:33 PM |
Throne Jason | Chief Legal Officer | Aug 09, 2023 | Option Exercise | $13.34 | 5,000 | 66,700 | 5,000 | Aug 11, 2023, 07:22 PM |
Throne Jason | Chief Legal Officer | Aug 09, 2023 | Sale | $25.09 | 5,000 | 125,429 | 0 | Aug 11, 2023, 07:22 PM |
Stone Paul A. | Chief Financial Officer | Aug 09, 2023 | Sale | $25.05 | 2,500 | 62,613 | 19,303 | Aug 11, 2023, 07:21 PM |
Throne Jason | Chief Legal Officer | Jul 10, 2023 | Option Exercise | $10.09 | 9,485 | 95,740 | 9,485 | Jul 12, 2023, 05:25 PM |
Throne Jason | Chief Legal Officer | Jul 10, 2023 | Sale | $23.00 | 9,485 | 218,178 | 0 | Jul 12, 2023, 05:25 PM |
Throne Jason | Chief Legal Officer | May 31, 2023 | Option Exercise | $7.01 | 432 | 3,028 | 432 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | Jun 01, 2023 | Option Exercise | $7.01 | 3,553 | 24,907 | 3,553 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | May 31, 2023 | Sale | $23.00 | 432 | 9,938 | 0 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | Jun 01, 2023 | Sale | $23.02 | 3,553 | 81,792 | 0 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | May 22, 2023 | Option Exercise | $7.01 | 500 | 3,505 | 500 | May 24, 2023, 05:51 PM |
Throne Jason | Chief Legal Officer | May 22, 2023 | Sale | $23.00 | 500 | 11,500 | 0 | May 24, 2023, 05:51 PM |
Stone Paul A. | Chief Financial Officer | Apr 13, 2023 | Option Exercise | $4.62 | 8,000 | 36,960 | 21,803 | Apr 14, 2023, 01:20 PM |
Hata Yujiro S | President and CEO | Apr 12, 2023 | Option Exercise | $4.31 | 11,601 | 50,000 | 677,887 | Apr 13, 2023, 04:11 PM |
Stone Paul A. | SVP, Chief Financial Officer | May 28, 2021 | Option Exercise | $11.36 | 859 | 9,762 | 13,803 | Apr 14, 2022, 04:10 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Oct 04, 2021 | Option Exercise | $11.08 | 1,500 | 16,620 | 80,289 | Oct 07, 2021, 04:11 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Oct 04, 2021 | Sale | $26.36 | 1,500 | 39,545 | 79,789 | Oct 07, 2021, 04:11 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 08, 2021 | Option Exercise | $6.87 | 11,384 | 78,264 | 90,173 | Sep 09, 2021, 07:24 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 07, 2021 | Option Exercise | $4.31 | 116 | 500 | 78,905 | Sep 09, 2021, 07:24 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 08, 2021 | Sale | $27.42 | 11,384 | 312,093 | 78,989 | Sep 09, 2021, 07:24 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 07, 2021 | Sale | $27.46 | 116 | 3,185 | 78,789 | Sep 09, 2021, 07:24 PM |
Stone Paul A. | SVP, Chief Financial Officer | Sep 07, 2021 | Sale | $27.42 | 2,500 | 68,542 | 12,944 | Sep 09, 2021, 05:41 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 02, 2021 | Sale | $25.09 | 10,000 | 250,943 | 78,789 | Sep 07, 2021, 06:48 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Aug 09, 2021 | Option Exercise | $4.31 | 1,500 | 6,465 | 100,289 | Aug 11, 2021, 05:19 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Aug 09, 2021 | Sale | $22.98 | 11,500 | 264,269 | 89,189 | Aug 11, 2021, 05:19 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 27, 2021 | Option Exercise | $5.62 | 10,000 | 56,150 | 108,789 | Jul 29, 2021, 05:18 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 27, 2021 | Sale | $25.15 | 10,000 | 251,460 | 98,789 | Jul 29, 2021, 05:18 PM |
Throne Jason | SVP, General Counsel | Jul 27, 2021 | Option Exercise | $13.34 | 10,000 | 133,400 | 10,000 | Jul 29, 2021, 05:17 PM |
Throne Jason | SVP, General Counsel | Jul 27, 2021 | Sale | $25.17 | 10,000 | 251,683 | 0 | Jul 29, 2021, 05:17 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 06, 2021 | Option Exercise | $6.92 | 1,500 | 10,380 | 100,289 | Jul 08, 2021, 07:01 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 06, 2021 | Sale | $22.24 | 1,500 | 33,358 | 98,889 | Jul 08, 2021, 07:01 PM |
Throne Jason | SVP, General Counsel | Jul 06, 2021 | Option Exercise | $8.52 | 10,000 | 85,229 | 10,000 | Jul 08, 2021, 07:00 PM |
Throne Jason | SVP, General Counsel | Jul 06, 2021 | Sale | $22.24 | 10,000 | 222,408 | 3,532 | Jul 08, 2021, 07:00 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Feb 09, 2021 | Option Exercise | $6.92 | 5,000 | 34,600 | 103,789 | Feb 10, 2021, 07:31 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Feb 09, 2021 | Sale | $20.74 | 5,000 | 103,696 | 98,789 | Feb 10, 2021, 07:31 PM |
Lackner Mark | SVP, Head of Biology | Feb 08, 2021 | Option Exercise | $6.98 | 300 | 2,094 | 300 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 10, 2021 | Option Exercise | $6.98 | 596 | 4,160 | 596 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 09, 2021 | Option Exercise | $6.98 | 1,104 | 7,706 | 1,104 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 10, 2021 | Sale | $21.00 | 596 | 12,516 | 0 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 09, 2021 | Sale | $21.05 | 1,104 | 23,234 | 0 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 08, 2021 | Sale | $21.01 | 300 | 6,302 | 200 | Feb 10, 2021, 06:53 PM |
BVF PARTNERS L P/IL | See Explanation of Responses | Feb 02, 2021 | Sale | $18.00 | 46,409 | 835,362 | 1,642,186 | Feb 04, 2021, 05:15 PM |
Lackner Mark | SVP, Head of Biology | Jan 26, 2021 | Option Exercise | $6.39 | 1,500 | 9,580 | 2,501 | Jan 28, 2021, 04:59 PM |
Lackner Mark | SVP, Head of Biology | Jan 26, 2021 | Sale | $18.46 | 2,501 | 46,158 | 800 | Jan 28, 2021, 04:59 PM |
Hata Yujiro S | President and CEO | Dec 22, 2020 | Option Exercise | $4.31 | 8,000 | 34,480 | 666,286 | Dec 23, 2020, 04:06 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Dec 18, 2020 | Option Exercise | $4.31 | 7,750 | 33,402 | 98,789 | Dec 22, 2020, 05:35 PM |
Throne Jason | SVP, General Counsel | Dec 04, 2020 | Sale | $15.37 | 1,979 | 30,410 | 1,579 | Dec 08, 2020, 04:03 PM |
5AM Ventures IV, L.P. | 10% Owner | Nov 11, 2020 | Sale | $13.66 | 800,000 | 10,928,000 | 2,187,428 | Nov 13, 2020, 08:53 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 30, 2020 | Buy | $13.32 | 2,531 | 33,704 | 1,667,420 | Jul 02, 2020, 06:51 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 22, 2020 | Buy | $13.93 | 19,732 | 274,960 | 1,665,899 | Jun 22, 2020, 07:52 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 19, 2020 | Buy | $14.39 | 98,264 | 1,413,970 | 1,655,375 | Jun 22, 2020, 07:52 PM |
Stone Paul A. | Chief Financial Officer | Jun 17, 2020 | Option Exercise | $4.62 | 3,100 | 14,322 | 18,100 | Jun 19, 2020, 07:46 PM |
Stone Paul A. | Chief Financial Officer | Jun 17, 2020 | Sale | $17.97 | 3,100 | 55,717 | 15,600 | Jun 19, 2020, 07:46 PM |
Lackner Mark | SVP, Head of Biology | Jun 17, 2020 | Option Exercise | $4.62 | 373 | 1,723 | 373 | Jun 18, 2020, 06:03 PM |
Lackner Mark | SVP, Head of Biology | Jun 16, 2020 | Option Exercise | $5.62 | 6,750 | 37,942 | 6,750 | Jun 18, 2020, 06:03 PM |
Lackner Mark | SVP, Head of Biology | Jun 17, 2020 | Sale | $19.91 | 373 | 7,428 | 0 | Jun 18, 2020, 06:03 PM |
Lackner Mark | SVP, Head of Biology | Jun 16, 2020 | Sale | $14.93 | 6,750 | 100,761 | 0 | Jun 18, 2020, 06:03 PM |
Throne Jason | VP, General Counsel | Jun 04, 2020 | Sale | $8.66 | 2,205 | 19,087 | 0 | Jun 08, 2020, 04:51 PM |
Lackner Mark | SVP, Head of Biology | Jun 02, 2020 | Sale | $9.21 | 845 | 7,779 | 437 | Jun 04, 2020, 05:40 PM |
Hata Yujiro S | President and CEO | Apr 15, 2020 | Option Exercise | $4.31 | 47,564 | 205,001 | 658,286 | Apr 16, 2020, 05:33 PM |
Stone Paul A. | Chief Financial Officer | Mar 30, 2020 | Option Exercise | $4.62 | 5,000 | 23,100 | 15,000 | Apr 01, 2020, 04:06 PM |
Hata Yujiro S | President and CEO | Jul 30, 2019 | Option Exercise | $4.31 | 15,000 | 64,650 | 610,722 | Aug 01, 2019, 12:20 PM |
Hager Jeffrey | SVP, Chief Technology Officer | Jul 26, 2019 | Option Exercise | $4.31 | 5,197 | 22,399 | 127,853 | Jul 30, 2019, 07:20 PM |
Stone Paul A. | SVP, General Counsel | Jul 26, 2019 | Option Exercise | $4.62 | 10,000 | 46,200 | 10,000 | Jul 29, 2019, 04:27 PM |
Hager Jeffrey | SVP, Chief Technology Officer | Jul 10, 2019 | Option Exercise | $4.31 | 7,145 | 30,795 | 122,656 | Jul 26, 2019, 12:50 PM |
Hager Jeffrey | SVP, Chief Technology Officer | Jun 19, 2019 | Option Exercise | $4.31 | 8,628 | 37,187 | 115,511 | Jul 26, 2019, 12:50 PM |
Alexandria Venture Investments, LLC | 10% Owner | May 28, 2019 | Buy | $10.00 | 50,000 | 500,000 | 432,384 | May 30, 2019, 06:12 PM |
DIEKMAN JOHN D | Director | May 28, 2019 | Buy | $10.00 | 250,000 | 2,500,000 | 2,844,545 | May 28, 2019, 09:14 PM |
Stone Paul A. | SVP, General Counsel | May 28, 2019 | Buy | $10.00 | 250,000 | 2,500,000 | 2,844,545 | May 28, 2019, 09:08 PM |
5AM Ventures IV, L.P. | 10% Owner | May 28, 2019 | Buy | $10.00 | 750,000 | 7,500,000 | 2,844,545 | May 28, 2019, 08:40 PM |
SHANNON TIMOTHY M | Director | May 28, 2019 | Buy | $10.00 | 400,000 | 4,000,000 | 2,660,713 | May 28, 2019, 04:56 PM |
CANAAN X L.P. | 10% Owner | May 28, 2019 | Buy | $10.00 | 400,000 | 4,000,000 | 2,660,713 | May 28, 2019, 04:55 PM |
Owner | Relationship | Date | Value($) |
Ruiz Briseno Andres | See Remarks | 02/09/2024 | 92,045 |
Hata Yujiro S | President and CEO | 02/09/2024 | 101,531 |
Hata Yujiro S | President and CEO | 02/08/2024 | 326,763 |
Hata Yujiro S | President and CEO | 02/09/2024 | 1,072,715 |
Hata Yujiro S | President and CEO | 02/08/2024 | 3,422,835 |
Hata Yujiro S | President and CEO | 02/01/2024 | 2,707 |
Hata Yujiro S | President and CEO | 02/01/2024 | 28,260 |
Ruiz Briseno Andres | See Remarks | 01/22/2024 | 84,050 |
Ruiz Briseno Andres | See Remarks | 01/12/2024 | 76,026 |
Hata Yujiro S | President and CEO | 01/16/2024 | 270,405 |
Hata Yujiro S | President and CEO | 01/12/2024 | 52,845 |
Hata Yujiro S | President and CEO | 01/16/2024 | 2,519,968 |
Hata Yujiro S | President and CEO | 01/12/2024 | 490,913 |
Throne Jason | Chief Legal Officer | 12/18/2023 | 70,100 |
Throne Jason | Chief Legal Officer | 12/15/2023 | 133,400 |
Throne Jason | Chief Legal Officer | 12/15/2023 | 350,371 |
Hata Yujiro S | President and CEO | 12/15/2023 | 323,250 |
Hata Yujiro S | President and CEO | 12/15/2023 | 2,627,618 |
Ruiz Briseno Andres | See Remarks | 12/14/2023 | 68,002 |
Throne Jason | Chief Legal Officer | 11/03/2023 | 66,396 |
Throne Jason | Chief Legal Officer | 11/03/2023 | 155,360 |
Throne Jason | Chief Legal Officer | 09/12/2023 | 12,860 |
Throne Jason | Chief Legal Officer | 09/12/2023 | 30,005 |
Throne Jason | Chief Legal Officer | 09/01/2023 | 27,006 |
Throne Jason | Chief Legal Officer | 09/05/2023 | 22,338 |
Throne Jason | Chief Legal Officer | 09/05/2023 | 52,160 |
Throne Jason | Chief Legal Officer | 09/01/2023 | 63,063 |
Ruiz Briseno Andres | See Remarks | 09/01/2023 | 60,016 |
Stone Paul A. | Chief Financial Officer | 08/29/2023 | 144,352 |
Stone Paul A. | Chief Financial Officer | 08/21/2023 | 25,819 |
Stone Paul A. | Chief Financial Officer | 08/18/2023 | 100,820 |
Stone Paul A. | Chief Financial Officer | 08/16/2023 | 5,285 |
Throne Jason | Chief Legal Officer | 08/09/2023 | 66,700 |
Throne Jason | Chief Legal Officer | 08/09/2023 | 125,429 |
Stone Paul A. | Chief Financial Officer | 08/09/2023 | 62,613 |
Throne Jason | Chief Legal Officer | 07/10/2023 | 95,740 |
Throne Jason | Chief Legal Officer | 07/10/2023 | 218,178 |
Throne Jason | Chief Legal Officer | 05/31/2023 | 3,028 |
Throne Jason | Chief Legal Officer | 06/01/2023 | 24,907 |
Throne Jason | Chief Legal Officer | 05/31/2023 | 9,938 |
Throne Jason | Chief Legal Officer | 06/01/2023 | 81,792 |
Throne Jason | Chief Legal Officer | 05/22/2023 | 3,505 |
Throne Jason | Chief Legal Officer | 05/22/2023 | 11,500 |
Stone Paul A. | Chief Financial Officer | 04/13/2023 | 36,960 |
Hata Yujiro S | President and CEO | 04/12/2023 | 50,000 |
Stone Paul A. | SVP, Chief Financial Officer | 05/28/2021 | 9,762 |
Dillon Michael P. | SVP, Chief Scientific Officer | 10/04/2021 | 16,620 |
Dillon Michael P. | SVP, Chief Scientific Officer | 10/04/2021 | 39,545 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/08/2021 | 78,264 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/07/2021 | 500 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/08/2021 | 312,093 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/07/2021 | 3,185 |
Stone Paul A. | SVP, Chief Financial Officer | 09/07/2021 | 68,542 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/02/2021 | 250,943 |
Dillon Michael P. | SVP, Chief Scientific Officer | 08/09/2021 | 6,465 |
Dillon Michael P. | SVP, Chief Scientific Officer | 08/09/2021 | 264,269 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/27/2021 | 56,150 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/27/2021 | 251,460 |
Throne Jason | SVP, General Counsel | 07/27/2021 | 133,400 |
Throne Jason | SVP, General Counsel | 07/27/2021 | 251,683 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/06/2021 | 10,380 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/06/2021 | 33,358 |
Throne Jason | SVP, General Counsel | 07/06/2021 | 85,229 |
Throne Jason | SVP, General Counsel | 07/06/2021 | 222,408 |
Dillon Michael P. | SVP, Chief Scientific Officer | 02/09/2021 | 34,600 |
Dillon Michael P. | SVP, Chief Scientific Officer | 02/09/2021 | 103,696 |
Lackner Mark | SVP, Head of Biology | 02/08/2021 | 2,094 |
Lackner Mark | SVP, Head of Biology | 02/10/2021 | 4,160 |
Lackner Mark | SVP, Head of Biology | 02/09/2021 | 7,706 |
Lackner Mark | SVP, Head of Biology | 02/10/2021 | 12,516 |
Lackner Mark | SVP, Head of Biology | 02/09/2021 | 23,234 |
Lackner Mark | SVP, Head of Biology | 02/08/2021 | 6,302 |
BVF PARTNERS L P/IL | See Explanation of Responses | 02/02/2021 | 835,362 |
Lackner Mark | SVP, Head of Biology | 01/26/2021 | 9,580 |
Lackner Mark | SVP, Head of Biology | 01/26/2021 | 46,158 |
Hata Yujiro S | President and CEO | 12/22/2020 | 34,480 |
Dillon Michael P. | SVP, Chief Scientific Officer | 12/18/2020 | 33,402 |
Throne Jason | SVP, General Counsel | 12/04/2020 | 30,410 |
5AM Ventures IV, L.P. | 10% Owner | 11/11/2020 | 10,928,000 |
BVF PARTNERS L P/IL | 10% Owner | 06/30/2020 | 33,704 |
BVF PARTNERS L P/IL | 10% Owner | 06/22/2020 | 274,960 |
BVF PARTNERS L P/IL | 10% Owner | 06/19/2020 | 1,413,970 |
Stone Paul A. | Chief Financial Officer | 06/17/2020 | 14,322 |
Stone Paul A. | Chief Financial Officer | 06/17/2020 | 55,717 |
Lackner Mark | SVP, Head of Biology | 06/17/2020 | 1,723 |
Lackner Mark | SVP, Head of Biology | 06/16/2020 | 37,942 |
Lackner Mark | SVP, Head of Biology | 06/17/2020 | 7,428 |
Lackner Mark | SVP, Head of Biology | 06/16/2020 | 100,761 |
Throne Jason | VP, General Counsel | 06/04/2020 | 19,087 |
Lackner Mark | SVP, Head of Biology | 06/02/2020 | 7,779 |
Hata Yujiro S | President and CEO | 04/15/2020 | 205,001 |
Stone Paul A. | Chief Financial Officer | 03/30/2020 | 23,100 |
Hata Yujiro S | President and CEO | 07/30/2019 | 64,650 |
Hager Jeffrey | SVP, Chief Technology Officer | 07/26/2019 | 22,399 |
Stone Paul A. | SVP, General Counsel | 07/26/2019 | 46,200 |
Hager Jeffrey | SVP, Chief Technology Officer | 07/10/2019 | 30,795 |
Hager Jeffrey | SVP, Chief Technology Officer | 06/19/2019 | 37,187 |
Alexandria Venture Investments, LLC | 10% Owner | 05/28/2019 | 500,000 |
DIEKMAN JOHN D | Director | 05/28/2019 | 2,500,000 |
Stone Paul A. | SVP, General Counsel | 05/28/2019 | 2,500,000 |
5AM Ventures IV, L.P. | 10% Owner | 05/28/2019 | 7,500,000 |
SHANNON TIMOTHY M | Director | 05/28/2019 | 4,000,000 |
CANAAN X L.P. | 10% Owner | 05/28/2019 | 4,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 5,436,668 | 0.00493% | 18.35% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,925,094 | 0.22% | 27.9% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,630,292 | 1.73% | 15.94% | Other |
CAPITAL RESEARCH GLOBAL INVESTORS | 1,976,870 | 0.02% | 43.58% | Growth At A Reasonable Price |
HOLOCENE ADVISORS, LP | 1,700,135 | 0.24% | 64.59% | Growth At A Reasonable Price |
GEODE CAPITAL MANAGEMENT, LLC | 1,351,337 | 0.00503% | 16.38% | Other |
BAKER BROS. ADVISORS LP | 1,062,123 | 0.43% | No change | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 912,786 | 0.39% | 30.87% | Growth |
PLATINUM INVESTMENT MANAGEMENT LTD | 662,343 | 0.96% | -13.61% | Growth At A Reasonable Price, Value |
FISHER ASSET MANAGEMENT, LLC | 539,676 | 0.01% | 1611.9% | Other |
D. E. SHAW & CO., INC. | 529,506 | 0.02% | 21.35% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 466,271 | 0.03% | New | Event Driven |
CANDRIAM S.C.A. | 395,019 | 0.1% | -8.14% | Other |
UBS OCONNOR LLC | 74,575 | 0.19% | -40.88% | Value |
ALPS ADVISORS INC | 42,450 | 0.01% | -0.07% | Other |
AQR CAPITAL MANAGEMENT LLC | 15,879 | 0.00106% | -7.05% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View